Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
effient
Synonyms :
prasugrel
Class :
Antiplatelet agent, hematologic
Brand Name :
effient
Synonyms :
prasugrel
Class :
Antiplatelet agent, hematologic
Dosage Forms & StrengthsÂ
TabletÂ
5mgÂ
10mgÂ
Initial dose
:
60
mg
Tablet
Orally 
once a day
Maintenance dose: 10mg/day orally combined with 81-325mg/day aspirin
Acute Coronary Syndrome
<75 years:
Loading dose: 60mg orally
Maintenance dose: 10mg/day orally combined with 81-325mg/day aspirin
>75 years:
Not recommended due to intracranial bleeding
may increase the toxic effect of anti-platelet agents
may increase the toxic effect of anti-platelet agents
may increase the anti-coagulant effect of anti-platelet agents
may reduce the serum concentration of anti-platelet agents
may increase the toxic effect of anti-platelet agents
may increase the toxic effect of anti-platelet agents
The inhibition of gastrointestinal (GI) absorption by codeine leads to a decrease in the level or effectiveness of prasugrel
When both drugs are combined, there may be an increased risk of bleeding and fatal hemorrhage  
may increase the anti-platelet effect
may increase the anti-platelet effect
may increase the anti-platelet effect
may increase the anti-platelet effect
may increase the anti-platelet effect
may increase the anti-platelet effect
It may enhance the risk of bleeding by affecting coagulation when combined with omega-3 carboxylic acids
It may enhance the risk of adverse effects when combined with Platelets inhibitors
It may enhance the risk of adverse effects when combined with Platelets inhibitors
It may enhance the risk of adverse effects when combined with Platelets inhibitors
It may enhance the risk of adverse effects when combined with Platelets inhibitors
It may enhance the risk of adverse effects when combined with Platelets inhibitors
It may enhance the risk of adverse effects when combined with platelet Inhibitors
It may enhance the risk of adverse effects when combined with platelet Inhibitors
It may enhance the risk of adverse effects when combined with platelet Inhibitors
It may enhance the risk of adverse effects when combined with platelet Inhibitors
dexchlorpheniramine, dextromethorphan, and phenylephrine
It may enhance the risk of adverse effects when combined with platelet Inhibitors
It may enhance the risk of adverse effects when combined with platelet inhibitors
It may enhance the risk of adverse effects when combined with platelet inhibitors
when administered with prasugrel, andexanet alfa's therapeutic efficacy may be diminished
may enhance the effects by pharmacodynamic synergism when combined with prasugrel
telotristat ethyl: they may diminish serum concentrations of prasugrel
It may enhance the risk of adverse effects when combined with general anesthesia
It may enhance the risk of adverse effects when combined with general anesthesia
It may enhance the risk of adverse effects when combined with general anesthesia
It may enhance the risk of adverse effects when combined with general anesthesia
Frequency defined:Â Â
1-10%Â
Hypercholesterolemia/hyperlipidemiaÂ
Back painÂ
NauseaÂ
CoughÂ
FatigueÂ
LeukopeniaÂ
PyrexiaÂ
Pain in extremityÂ
HeadacheÂ
DyspneaÂ
DizzinessÂ
HypotensionÂ
Noncardiac arrestÂ
BradycardiaÂ
RashÂ
Peripheral edemaÂ
DiarrheaÂ
<1%Â
Abnormal hepatic functionÂ
HematomaÂ
HemorrhageÂ
AngioedemaÂ
HemolysisÂ
Abnormal liver functionÂ
Post-marketing reportsÂ
Hypersensitivity reactions: anaphylaxisÂ
ThrombocytopeniaÂ
Pregnancy consideration:Â Â
US FDA category: CÂ
Lactation: Excretion of the drug in human breast milk is unknownÂ
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Patient information leafletÂ
Generic Name: prasugrelÂ
Pronounced: [ PRA-soo-grel ]Â
Why do we use prasugrel?Â
It is used to prevent heart attacks, strokes, and other severe issues with your heart and blood vesselsÂ
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
